Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | PVLAPalvella Therapeutics, Inc.FY2023 · Dec |
|---|---|
| Revenue | $42.81M |
| Revenue, yoy | +65.3% |
| Net income | $41.72M |
| Net income, yoy | −139.3% |
| Net margin | — |
| Free cash flow | $13.87M |
| FCF margin | -32.4% |
| EPS, diluted | $3.71 |
Add another company.